[22]
As Mahoney, J.A., said in
Bayer AG
, supra, at p. 8:
"The court has a clear duty to deal with an application expeditiously. Given that, in the scheme of the
Regulations
, it is the patentee who has both the carriage of the proceeding and the interest in its dilatory prosecution, departures from the schedule imposed by the Part V.1
Rules
ought not be routine."